Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

0000950170-24-087886.txt

Celularity (NASDAQ:CELU)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Celularity Charts.

Celularity (NASDAQ:CELU)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Celularity Charts.

Celularity Inc News

Celularity Inc. Announces Receipt of Nasdaq Notification
Wednesday 27 November 2024 (5 days ago) • GlobeNewswire Inc.

Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Wednesday 20 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
Monday 18 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Thursday 7 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
Wednesday 23 October 2024 (1 month ago) • GlobeNewswire Inc.

Celularity Provides Corporate Update
Tuesday 22 October 2024 (1 month ago) • GlobeNewswire Inc.

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
Friday 18 October 2024 (1 month ago) • GlobeNewswire Inc.

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
Wednesday 16 October 2024 (2 months ago) • GlobeNewswire Inc.

Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
Thursday 5 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 August 2024 (3 months ago) • Edgar (US Regulatory)

Celularity Appoints Richard J. Berman to its Board of Directors
Wednesday 28 August 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 23 August 2024 (3 months ago) • Edgar (US Regulatory)

More Celularity Inc News Articles

Societe Generale Effekten

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions